Provided by Tiger Fintech (Singapore) Pte. Ltd.

iBio

0.8500
+0.00450.53%
Post-market: 0.85000.00000.00%19:29 EDT
Volume:738.39K
Turnover:645.01K
Market Cap:17.22M
PE:-0.49
High:0.9100
Open:0.8580
Low:0.8412
Close:0.8455
52wk High:6.89
52wk Low:0.5562
Shares:20.25M
Float Shares:18.61M
Volume Ratio:2.09
T/O Rate:3.97%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.7504
EPS(LYR):-1.7504
ROE:-101.52%
ROA:-44.79%
PB:1.16
PE(LYR):-0.49

Loading ...

iBio Initiated at Outperform by Leerink Partners

Dow Jones
·
Oct 17

Leerink Initiates iBio at Outperform With $2 Price Target

MT Newswires Live
·
Oct 17

iBio initiated with an Outperform at Leerink

TIPRANKS
·
Oct 17

Ibio Inc : Leerink Partners Initiates Coverage With Outperform Rating; Target Price $2

THOMSON REUTERS
·
Oct 17

Trump Excludes Generics From Big Pharma Tariff Plan

Dow Jones
·
Oct 09

iBio Inc. Announces Date for 2025 Annual Meeting of Stockholders

Reuters
·
Oct 07

Ibio Reports Fiscal Year 2025 Financial Results and Provides Corporate Update

THOMSON REUTERS
·
Sep 05

Press Release: iBio Reports Fiscal Year 2025 Financial Results and Provides Corporate Update

Dow Jones
·
Sep 05

iBio Announces Closing of $50 Million Public Offering

GlobeNewswire
·
Aug 25

iBio Inc. Announces Proposed Public Offering to Advance Preclinical Programs

Reuters
·
Aug 22

iBio Announces Pricing of $50 Million Public Offering

GlobeNewswire
·
Aug 19

IBio Launches Public Offering to Advance Preclinical Pipeline

MT Newswires Live
·
Aug 19

BRIEF-iBio Announces Proposed Public Offering

Reuters
·
Aug 19

Ibio Announces Proposed Public Offering

THOMSON REUTERS
·
Aug 19

Ibio Inc - to Use Proceeds for Preclinical Cardiometabolic Programs

THOMSON REUTERS
·
Aug 19

Impact Biomedical Inc (IBO) Announces 3F™ US Patent Issue

GlobeNewswire
·
Aug 18

iBio Inc. Faces Nasdaq Delisting Risk Due to Non-Compliance with Minimum Bid Price Requirement

Reuters
·
Aug 02

iBio Is Maintained at Buy by Chardan Capital

Dow Jones
·
Jun 25

BRIEF-Ibio And Astralbio Unveil Obesity Program With Novel Amylin Agonist Antibody Demonstrating Promising In Vivo Results

Reuters
·
Jun 24

iBio Inc. Announces Extension of Promissory Note with Safi Biotherapeutics, Requires Interest Payment for Extension

Reuters
·
Jun 18